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Abstract: Molecular methods may reveal the presence of pathogens in samples through the detection
of specific target gene(s) associated with microorganisms, but often, the subsequent cultural isolation
of the pathogen is not possible. This discrepancy may be related to low concentration of the cells,
presence of dead cells, competitive microflora, injured cells and cells in a viable but non-culturable
state, free DNA and the presence of free bacteriophages which can carry the target gene causing
the PCR-positive/culture-negative results. Shiga-toxigenic Escherichia coli (STEC) was used as a
model for studying this phenomenon, based on the phage-encoded cytotoxins genes (Stx family) as
the detection target in samples through real-time qPCR. Stx phages can be integrated in the STEC
chromosome or can be isolated as free particles in the environment. In this study, a combination
of PCR with culturing was used for investigating the presence of the stx1 and stx2 genes in
155 ovine recto-anal junction swab samples (method (a)-PCR). Samples which were PCR-positive
and culture-negative were subjected to additional analyses including detection of dead STEC cells
(method (b)-PCR-PMA dye assay), presence of Stx phages (method (c)-plaque assays) and inducible
integrated phages (method (d)-phage induction). Method (a) showed that even though 121 samples
gave a PCR-positive result (78%), only 68 samples yielded a culturable isolate (43.9%). Among the 53
(34.2%) PCR-positive/culture-negative samples, 21 (39.6%) samples were shown to have STEC dead
cells only, eight (15.1%) had a combination of dead cells and inducible stx phage, while two samples
(3.8%) had a combination of dead cells, inducible phage and free stx phage, and a further two samples
had Stx1 free phages only (3.8%). It was thus possible to reduce the samples with no explanation
to 20 (37.7% of 53 samples), representing a further step towards an improved understanding of the
STEC PCR-positive/culture-negative phenomenon.
Keywords: STEC; qPCR; bacteriophages; Stx phages; PMA; VBNC
1. Introduction
Shigatoxigenic Escherichia coli (STEC) are major zoonotic foodborne pathogens capable of
causing severe gastrointestinal diseases and complications such as haemorrhagic colitis (HC) and
haemolytic uremic syndrome (HUS) [1,2]. The main virulence factors of STEC are the phage-encoded
cytotoxins called Shiga toxins (Stx family), with several toxin subtypes [3]. Stx phages can be present,
either integrated in the STEC chromosome as temperate bacteriophage or as free particles in the
environment [4–6]. STEC strains are genetically heterogeneous and grouped as serotypes, and the
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serotype O157:H7 has been reported as the causative agent of large outbreaks of food-borne disease
and most reported in the literature [7–10]. However, the emergence of non-O157 serotypes as agents
responsible for foodborne outbreaks including O26:H11, O111:NM, O103:H2, and O145:NM with
different combinations of toxin subtypes [11–17], has increased the importance of developing effective
methods for the detection and characterization of a wider range of STEC [18]. Culture-dependent
detection methods for screening STEC in samples include enrichment in selective media and subsequent
use of DNA-based methods for their detection and quantification such as real-time quantitative PCR
(qPCR) for stx genes, followed by cultural isolation (ISO, 2012; CEC, 2005-EC 2073).
Even though PCR- and qPCR-positive results may indicate the presence of stx in a sample,
often, the subsequent cultural isolation of the STEC strain is not possible, with large discrepancies
reported between PCR- and culture-positive results across a range of sample matrices. This is a
common finding in PCR-based STEC detection, in ovine [19], bovine [20] and human stool samples [21].
This significant discrepancy may be related to low concentration of the cells [22], presence of dead
cells [23], presence of competitive microflora [24], injured cells and cells in a viable but non-culturable
(VBNC) state [25], cell-free DNA [26], or may also be due to the presence of free Stx phage particles in the
samples [27,28], resulting in the PCR-positive/culture-negative phenomenon [29–32]. The investigation
of these occurrences and their underlying causes will support risk assessment and method enhancement
for STEC detection. In this study, three different protocols in addition to the standard protocol were
applied to test samples to assess the cause of stx PCR-positive culture-negative samples identified by a
standard real time quantitative PCR protocol in ovine recto-anal junction samples. The generated data
can be seen as representative of other matrices and is a further step towards an improved understanding
of the STEC PCR-positive/culture-negative phenomenon.
2. Materials and Methods
2.1. Sheep Recto-Anal Junction Samples Examined for STEC
In this study, 155 ovine recto-anal junction (o-RAJ) swab samples were collected between February
and May 2019 from two different ovine slaughtering facilities. As this study utilised recto-anal junction
swab samples which were collected from sheep in the abattoir after slaughter it was not necessary to
obtain approval from the animal ethics committee. One foam-over-cotton head wood handle swab
(VWR, Dublin, Ireland) pre-soaked in 1 mL of maximum recovery diluent (Oxoid, Dublin, Ireland) was
inserted approximately 3–5 cm into the RAJ area using a rapid in and out motion. The samples were
transported to the laboratory and stored at 4 ◦C, and microbiological analyses were started within 24 h
after sampling. Each swab was transferred into 30 mL of modified Tryptone Soya Broth (TSB, Oxoid,
Dublin, Ireland) with 16 mg/l novobiocin (Oxoid, Basingstoke, UK) and incubated at 41.5 ◦C for 24 h
obtaining the enriched samples. The four protocols used in this study are presented in Figure 1 and are
as follows: (a) standard qPCR and culture approach; (b) viability dye assay to identify the presence of
dead cells; (c) to assess for presence free phage and; d) phage induction. Method (a) was used on all
samples and methods (b), (c) and (d) on PCR-positive, culture-negative samples.
2.2. Real-Time PCR (qPCR) and Culture
Following enrichment, the total genomic DNA was extracted with InstaGene Matrix (Bio-Rad,
Watford, UK). Briefly, 1 mL of each enriched sample was centrifuged for 10 min at 10,000× g, the pellet
was resuspended in 1 mL of phosphate-buffered saline (PBS) (Oxoid, Basingstoke, UK), then centrifuged
at 10,000× g for 10 min. The obtained pellet was resuspended in 100 µL of matrix and incubated at
56 ◦C for 30 min followed by incubation at 95 ◦C for 15 min. The suspensions were centrifuged at
15,000 × g for 5 min and supernatants were used as real-time PCR templates in a duplex real-time PCR
assay for the detection of the genes stx1 and stx2 and performed on the LightCycler 480 (LC480) (Roche
Diagnostics, Burgess Hill, UK). The primers and hydrolysis probes used are reported in Table 1.
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Figure 1. Methods used to investigate the cause of PCR-positive/culture-negative samples for STEC.
The methods were applied to the examination of sheep recto-anal junction swab samples. The methods
were as follows: (a) real-time PCR (qPCR) and culture method; (b) propidium monoazide pre-treatment
and real-time PCR (qPCR-PMA); (c) bacteriophage detection and plaque assay; (d) phage induction.
qPCR = real-time PCR; CFS = cell free supernatant; PMA = propidium monoazide.
Table 1. Primers and probes used for the amplification of stx genes.








Probe Hex- TCGTCAGGCACTGTCTGAAACTGCT C-BHQ2
Each reaction consisted of 2.4 µL of 5× LightCycler Multiplex Master (Roche Diagnostics, Burgess
Hill, UK), 0.1 µL hydrolysis probes (0.1 µM), 0.7 µL of the forward and reverse primers (0.6 µM),
and 2 µL of target template DNA, made up a 12 µL volume reaction with water. A positive and
negative DNA control and a no template control (NTC) were included in each real-time PCR run.
The cycling conditions were as follows: pre-incubation at 95 ◦C for 5 min, followed by 42 cycles (95 ◦C
for 15 s, 60 ◦C for 60 s and 72 ◦C for 1 s). Data analysis was performed using the real-time Lightcycler
PCR software. Positives samples were then plated on MacConkey agar (Oxoid, Basingstoke, UK) and
incubated at 37 ◦C for 24 h.
A total of five pools containing five single colonies for each sample were extracted, suspending
the colonies in 100 µL of PBS and proceeding with DNA extraction. The five single colonies were
then collected and characterized from the positive pools. The positive control strains included E.coli
O157:H7 (ATCC 35150) and E.coli O26:H11 (CDC 03-3014) (both stx1 and stx2 positive) and were
cultured in TSB at 37 ◦C for 18 h, harvested by centrifugation (10 min at 10,000× g) and washed with
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PBS. Cells were then re-suspended in 100 µL of InstaGene matrix and DNA extracted following the
described protocol.
2.3. Pre-Treatment with Propidium Monoazide and Real Time PCR (qPCR-PMA)
In order to investigate the presence of dead cells (Figure 1b), the enriched samples were treated
with a 25 µM final concentration of propidium monoazide—PMAxx (Biotium, Fremont, CA, USA)
and stored at room temperature in the dark for 10 min. The samples were exposed to intense visible
light for 20 min with the use of the LED Photolysis Device (PMA-Lite, Biotium, Fremont, CA, USA).
The treated cultures were centrifuged at 5000× g for 10 min and the pellets were used as templates for
total genomic DNA extraction. In addition, 500 µL of the positive control strains were inactivated at
95 ◦C for 5 min (heat killed controls, HK) and used as dead cells suspension controls. 250 µL of the HK
positive controls were resuspended with 250 µL of corresponding live positive controls to generate
a 50% (v/v) mixture of live and dead cells suspension from which DNA was extracted following the
PMA treatment protocol.
2.4. Detection of Free Bacteriophages
To investigate if there were free bacteriophages in the samples (Figure 1c), samples were
purified by centrifuging 2 mL of enriched samples and the supernatants were passed through
low-protein-binding 0.22 µm-pore-size membrane filters (Agilent Technology, Didcot, UK), obtaining
the cell free supernatants (CFS). One ml of CFS was plated on tryptone soya agar (TSA) (Oxoid, Dublin,
Ireland) and incubated at 37 ◦C for 24 h in order to verify the absence of bacteria. The putative
bacteriophage suspensions were then treated with DNase (100 units/mL of CFS) (Sigma-Aldrich,
Wicklow, Ireland) to eliminate free DNA outside the phage particles, and incubated at 37 ◦C for
1 h, after which 10 µL of EDTA (Sigma-Aldrich, Wicklow, Ireland) (final concentration 0.5 mM) was
added to inactivate the DNase and incubated at 65 ◦C for 10 min (purified phage suspension, PPS).
Two aliquots of the samples at this stage were used for the plaque assay (aliquot 1) described below
and as a template for stx1 and stx2 qPCR (aliquot 2) in order to confirm the absence of free target DNA.
The DNA from all phages, presumably present in the PPS, was isolated with a digestion treatment,
adding 5 µl of Proteinase K (Sigma-Aldrich, Wicklow, Ireland) per ml of PPS and incubated at 56 ◦C
for 1h. This final bacteriophage DNA suspension was purified with a phenol-chloroform (1:1, v/v)
treatment, as described previously [34].
2.5. Phage Induction
To determine the presence of inducible phage among the samples, one aliquot of 5 mL of the
enriched sample was transferred to a fresh tube containing mitomycin C (MMC) to a final concentration
of 0.5 µg/mL (Figure 1d). The samples were incubated for 18 h at 37 ◦C in the dark on a shaker.
The induced-phage DNA was prepared following the protocol described for the phage detection.
2.6. Plaque Assay
The purified phage suspensions obtained from the enriched sample and from the MMC pre-treated
samples were diluted 10-fold and tested for plaque production. Briefly, 0.5 mL of an overnight
Luria-Bertani (LB) broth (Oxoid, Dublin, Ireland) culture of the indicator E.coli K12 strain C600
containing 2 × 108 CFU/mL was added to 100 µL of 0.1 M CaCl2 and incubated for 30 min at 37 ◦C.
The suspensions were then gently mixed with 5 mL of soft-TSA (tryptone soya broth with 0.75% v/v
agar), poured onto TSA plates and allowed to dry; 10 µL of each phage suspension and the 10-fold
dilutions were poured on the plates creating a spot onto the bacterial lawn. After incubation for 18 to
24 h at 37 ◦C, the plates were examined for the presence of lysis zones indicating the presence of free
phage particles in the sample. For infectivity studies and phages stocks, the plaques of lysed samples in
qPCR-positive and culture-negative samples were removed with a wire loop and suspended in 500 µL
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of TSB. The suspensions were filtered through low-protein-binding 0.22-µm-pore-size membrane filters
and 10 µL were spotted onto a monolayer of the host strains as described above for infectivity tests.
3. Results
Among the o-RAJ samples (n = 155) examined, method (a) (qPCR coupled with culture), showed
121 samples (78.1%) positive for STEC DNA, but it was only possible to isolate STEC from 68 of the
samples (43.9%), i.e., a PCR-positive, culture-negative rate of 34.2% (53 samples). In total, 82 strains
were recovered (>1 isolate from some samples) and differing stx profiles were observed. The majority
of the strains were positive for both stx genes (n = 41), whilst 23 strains were positive for stx1 only and
18 strains were positive for stx2 only.
3.1. Real-Time PCR Results and Comparison with PMA-qPCR
The crossing point (Cp) values obtained with the qPCR were compared with the Cp values of the
samples pre-treated with PMAxx. The effects of PMAxx-mediated inhibition of amplification of the
control strain DNA is shown in Figure S1A,B for stx1 and stx2, respectively (Supplementary Material),
by using DNA derived from live cells (amplification curve 1), HK suspension (amplification curve 3)
and a 50% (v/v) mixture (amplification curve 2). The results showed a 15-Cp value difference between
the live cells and HK, demonstrating that PMAxx treatment efficiently suppressed DNA amplification
from the dead cells for both targets.
For this study, the untreated and PMAxx-treated samples were analysed in the same qPCR
runs in order to evaluate the effect of the PMA-mediated inhibition on the obtained Cp values.
The samples were considered negative for the targeted sequences if the Cp values were greater than
30 and if the Cp from PMA-qPCR was greater than the value (cutoff = 2 Cp) of the non-treated
samples (Cp PMA-qPCR>Cp qPCR), this signal was deemed to be from mostly dead cells. Among
the PCR-positive/culture-negative samples (n = 53), the comparison of the standard qPCR with the
PMA-qPCR highlighted 31 samples in total (59.6% of 53 samples) with amplification from dead or
damaged cells in culture.
3.2. Detection of Free Bacteriophages and Inducible Prophages
In this study, all PCR-positive culture-negative samples were tested for the presence of free
bacteriophage particles in the enrichment and the presence of MMC-inducible prophages through a
plaque assay. Among the 53 samples, 17 (11.0%) were positive for the plaque assay, but only four
(2.6%) samples were positive with the CFS-qPCR. In particular, one CFS sample was positive for stx1
and three CFS samples were positive for stx2 (Table 2). In total, 26 samples pre-treated with MMC
were positive for the formation of plaques (16.8%). Among those, 13 samples were positive with the
CFS-qPCR for at least one stx gene, including six CFS samples positive for stx2 and seven CFS samples
positive for both stx1 and stx2.
In 13 CFS samples (8.4%) and 13 MMC pre-treated CFS samples (8.4%), which were positive for
the plaque assay, it was not possible to detect the stx genes by qPCR.
Sample 12 was positive for Stx1 phage DNA and samples 51, 55 and 99 were positive for Stx2
phages and were also positive for the plaque assay. These enriched samples were positive at the qPCR
for both stx genes, except Sample 99 which was positive for stx1 only (Table 3). Aliquot 2, collected for
confirming the absence of free target DNA in the PPS, resulted negative to stx1 and stx2 qPCR.
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Table 2. Stx gene profiles, tested by qPCR, of the samples positive with the plaque assay. These include
samples examined for free phage (Figure 1c) and for phage induction (Figure 1d).
Sample n qPCR/Culture Result
Detection of Free Bacteriophages MMC Treatment
Stx1 Stx2 Plaque Stx1 Stx2 Plaque
12 pos/neg + − + − − +
31 pos/neg − − + − − +
32 pos/neg − − − − − +
51 pos/neg − + + + + +
52 pos/neg − − + − − +
53 pos/neg − − + − + +
54 pos/neg − − + + + +
55 pos/neg − + + − + +
57 pos/neg − − + − − +
60 pos/neg − − − − − +
62 pos/neg − − + − − +
63 pos/neg − − − + + +
74 pos/neg − + − − + +
75 pos/neg − + − + + +
76 pos/neg − − + − + +
77 pos/neg − − − − + +
88 pos/neg − − + − − +
92 pos/neg − − − − − +
93 pos/neg − − + + + +
94 pos/neg − − + + + +
97 pos/neg − − − − − +
99 pos/neg − + + + + +
109 pos/neg − + − − − +
125 pos/neg − − + − − +
151 pos/neg − − + − − +
152 pos/neg − − + − + +
qPCR: real-time PCR; pos: positive, neg: negative; MMC = Mitomycin C.
Table 3. Effect of the stx bacteriophages to qPCR-positive/culture-negative results.
Sample n
Enriched Samples Detection of Free Bacteriophages MMC Treatment
Stx1 Stx2 Stx1 Stx2 Plaque Stx1 Stx2 Plaque
12 + + + − + − − −
51 + + − + + + + +
55 + + − + + − + +
99 + − − + + + + +
MMC = Mitomycin C.
4. Discussion
Different studies have reported the detection of STEC by PCR or qPCR from different
matrices [35–38] and the challenges of subsequently obtaining cultured STEC isolates. This significant
discrepancy may be related to dead and injured cells, cells in a viable but non-culturable (VBNC)
state, the presence of free DNA and free Stx bacteriophages in the samples [10,39–44]. In addition,
the microbial communities can have an important influence on the survival capabilities of STEC in
environmental substrates and consequential cultural isolation [24,45].
In this study we applied a number of different methods to better understand the phenomenon
and evaluate their application in analysing STEC results. In this case the methodology was applied
to o-RAJ swab samples, but the approach should be applicable to other sample types also. With this
approach, the percentage of samples which were PCR-positive/culture-negative without an explanation
were reduced from 53 to 20 samples (34.2% to 12.9% of 155 samples, respectively), demonstrating that
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there is a need to develop novel approaches to better understand this phenomenon. A total of five
pools containing five single colonies for each sample were picked-up from the agar and extracted,
and from positive pools, the five single colonies were collected and characterized. The number and
diversity of the agar reflects the variety of fermentative profiles of different STEC, which would suggest
the use of several agars, but the percentage obtained of recovered culturable STEC in this study
(PCR-positive/culture-negative samples), were similar to other reports [19–21,29,36].
The PMA-qPCR provided valuable information to asses if viable cells were present in the sample,
supporting risk management. In addition, the evaluation of the presence of free bacteriophages
demonstrates the complexity of the samples and that the incidence of culture-negative samples is often
due to different agents and conditions within the ecology of the sample.
The combination of the results with the PMA-qPCR demonstrated the presence of dead cells in
samples which tested PCR-positive by the standard assay. The presence of dead or damaged cells in
culture was detected in 31 samples (58.5% of the PCR-positive/culture-negative), which were not able to
form colonies in culture, illustrating why cultural isolation was not successful and demonstrating their
contribution to the PCR-positive, culture-negative phenomenon. In this study, it was possible to detect
two samples with free Stx phage particles (3.8% of PCR-positive/culture-negative samples) in CFS but
with the use of PMA-qPCR it was also possible to identify dead cells in the samples, together with free
Stx particles and inducible Stx phages in two samples (3.8%) and in eight samples with inducible Stx
phages (15.1%) (Figure 2b), further demonstrating the differing causes for culture negative samples.
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Figure 2. Results of the approaches used in this study. (a) Results of the STEC screening (method a) of
the o-RAJ samples (n = 155). (b) Results of the combination of the methods used to investigate the
qPCR-positive/culture-negative phenomenon (n = 53).
The stx1 and stx2 genes are mobile virulence factors, located on the genome of temperate
bacteriophages [46–49] which are able to integrate in the E.coli genome during lysogeny, resulting in
acquired ability to express the Shiga toxin [29]; however, the prophages can be induced to enter the
lytic cycle producing toxin and new phage particles [50]. In this study, mitomycin C was used for the
lytic cycle induction in the enriched samples resulting in an increase of number of positive samples for
the plaque assay (Table 2, 35 samples). The same samples were tested for the extraction of free phage
particles and 20 o-RAJ samples were positive for the amplification of at least one stx gene, suggesting
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the presence in the enriched samples of STEC integrated prophages, even though the cells were not
culturable. Ten samples were plaque positive after the MMC pre-treatment even though were negative
for free bacteriophages with method (c) (Figure 1); seven of them were in fact negative for both the stx
genes and three were positive for stx2. Interestingly, Sample 63 was negative for free phage particles in
culture (CFS) but was positive for both stx1 and stx2 after induction. This result may be due to the
presence of low number of STEC cells in the samples with inducible prophages; in fact, metabolically
active cells, rather than dormant cells, are required by bacteriophages to replicate their nucleic acids.
It was not possible to confirm that the phages from the positive plaques were infective. This may be
due to the possibility that the phages, instead of replicating in the host strains causing lysis, remained
integrated in the bacterial genome and generated lysogens as suggested by Imamovic and Muniesa [51].
In this study, TSB modified with 16 mg/L novobiocin (mTSB) was used as enrichment broth for 24h of
incubation. It has been reported that for some serogroups and concentrations higher than 20 mg/L
the growth of such strains is slowed down or has an effect on the viability of STEC [52]. However,
the standard method ISO/TS 13136:2012 indicates 16 mg/L as a concentration of novobiocin in the
mTSB for the enrichment step, which was used in different studies [19,53–56].
The deficit between PCR- and culture-positive prevalence rates is comparable with other reported
surveys [57,58] and with the combination of the methods used in this study it was possible to evaluate
the effect of Stx bacteriophages and dead cells on the positivity of qPCR. Sample 12 was positive for
stx1 and stx2 with the standard qPCR (enrichment sample) and free stx1 phage was detected but the
samples resulted negative for the induction, indicating the presence of only free stx1 bacteriophage
particles in the sample (Table 3). Samples 51 and 55 were positive for the amplification of the stx1 and
stx2 genes in the enriched samples, and free stx2 phage particles were also detected. Additionally,
induced prophages were detected in both sample 51 (stx1/stx2 detected) and only the stx2 in sample 55
(Table 3). Interestingly, Sample 99 tested positive for stx1 in the enriched sample (Table 3) but only
stx2 phage DNA was detected in the CFS and both stx genes were detected in the induced samples.
This result suggested the presence of free stx2 phage in the sample and also the presence of stx1 and
stx2 induced prophage in cells. The number of cells with stx2 gene was probably present in the sample
in a low number, not detectable with the qPCR.
Two samples contained free stx-encoding phages and, in total, 31 samples with dead cells were
detected, with or without free phage particles and inducible prophages. In total, 13 samples were plaque
positive but the qPCR for the stx genes resulted negative. This result demonstrates the complexity
of the samples and the presence of a heterogeneous population of bacteriophages and prophages in
the microbiota of the tested animals unrelated to stx carriage which might also cause the formation of
the plaques.
Whilst it was not possible to explain the qPCR-positive culture-negative phenomenon for
20 samples, the generated data demonstrate the reduction of the number of the occurrences of the
phenomenon from 34.2% to 12.9% and represents a further step towards improving the understanding
of the biology of this phenomenon, giving a valid support for risk managers and public health
prospective regarding qPCR-positive/culture-negative results for o-RAJ swab samples which requires
a public health risk assessment.
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